News
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Vifor Pharma today announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult
Pfizer Declares First-Quarter 2022 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to $0.40 for the first-quarter 2022 dividend
DGAP-News: BP p.l.c.: Transaction in Own Shares
Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant
Exelon Corp. (Nasdaq: EXC) hosted U.S. Secretary of Energy Jennifer M. Granholm on a tour of Exelon’s Braidwood Generating Station in Will County to highlight the economic and environmental
Okta Joins the OpenID Foundation Board to Further Advance Open Identity Standards
Okta, Inc. (NASDAQ:OKTA), the leading independent provider of identity, today announced it has joined the OpenID Foundation as a sustaining member. The new board position for Okta follows
Cloudflare Joins Microsoft 365 Networking Partner Program; Optimizes Cloudflare’s Zero Trust Network for Microsoft Customers
Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today announced it has joined the Microsoft 365 Networking Partner Program
European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor
RPM to Announce Fiscal 2022 Second-Quarter Results on January 5, 2022
RPM International Inc. (NYSE: RPM) announced today that it will release its financial results for the fiscal 2022 second quarter ended November 30, 2021, before the stock market opens on Wednesday
Guidewire Announces NXT Level Technologies as New Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that NXT Level Technologies, an insurance IT services provider specializing in Guidewire products, has joined Guidewire PartnerConnect as a Consulting alliance
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Victory Capital Reports November 2021 Assets Under Management
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today reported assets under management (AUM) of $160.5 billion as of November 30, 2021.
Victory Capital
CI Global Asset Management Announces ETF Mergers
CI Global Asset Management (“CI GAM”) today announced a proposal to merge six exchange-traded funds into other ETFs as part of its continuing strategy to modernize its product lineup.
The
Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that on December 6, 2021, its Board of Directors appointed a new member, Ms. Dessislava (“Dessi”) Temperley.
Dessi Temperley is a
Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices
Today, in recognition of International Day of Human Rights and the International Year for the Elimination of Child Labor (2021), Philip Morris International Inc. (PMI) (NYSE: PM) publishes its
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 46 / 2021) with DEGES
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
Germany Slowly Joins Europe in Adopting Data Analytics
Germany lags behind most of Europe in digital transformation and the use of advanced analytics services but is gradually gaining momentum, according to two new research reports published today by
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 45 / 2021) with ACCIONA
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.
Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc
Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced the appointment of Hervé Gisserot as Chief Commercial Officer and member of the Vifor Pharma
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor